Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
100%(7 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
1
11%
Ph phase_2
4
44%
Ph phase_3
4
44%

Phase Distribution

0

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
4(44.4%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (44.4%)
Phase 34 (44.4%)
N/A1 (11.1%)

Trials by Status

unknown111%
terminated111%
completed778%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_3

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

NCT02577406
completedphase_2

Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia

NCT04333420
completedphase_2

A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis

NCT02688647
terminatedphase_3

Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia

NCT04369469
completednot_applicable

Effects of CPAP on Cognitive Function, Neurocognitive Architecture and Function in Patients With OSA: The SMOSAT Trial

NCT02886156
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT02577406Phase 3

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

Completed
NCT04333420Phase 2

Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia

Completed
NCT02688647Phase 2

A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis

Completed
NCT04369469Phase 3

Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia

Terminated
NCT02886156Not Applicable

Effects of CPAP on Cognitive Function, Neurocognitive Architecture and Function in Patients With OSA: The SMOSAT Trial

Completed
NCT01529112Phase 2

A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments

Completed
NCT02149108Phase 3

Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)

Completed
NCT01140347Phase 3

A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib

Completed
NCT01356875Phase 2

Treatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive Chemotherapy

Unknown

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9